Applications open now for 2024 Launch summer accelerators

Are you an aspiring entrepreneur with a groundbreaking idea itching to hit the market? Look no further than Lab2Market Launch and Collide Launch, two dynamic 12-week summer accelerators designed to transform innovative concepts into thriving businesses. These initiatives serve as catalysts for budding entrepreneurs, offering them a platform to refine their ideas, connect with industry experts, and propel their ventures towards success. 

About Launch:

  • The Launch programs are for pre-seed entrepreneurial teams in Atlantic Canada who have spoken with customers and are ready to build a business model during a three-month intensive.  
  • Participants receive a $10,000 stipend plus additional opportunities to receive non-dilutive funding over the program. 
  • Lab2Market Launch is for research-focused ideas, while Collide Launch is open to all types of ventures. 

Learn more and apply now: 

Sign up for our newsletter and stay up to date with Dal Innovates.

About Dalhousie University

Dalhousie is the only East Coast member of Canada’s U15, the country’s leading group of research-intensive universities. With more than 250 million dollars in annual research funding, we are Atlantic Canada’s engine of discovery and innovation. Anchored in Halifax, Nova Scotia, with additional agricultural and medical campuses and academic and clinical programs across the province and beyond, we drive positive change in the communities we serve locally, nationally, and around the world. Our faculty work within a highly collaborative research community supported by major infrastructure, including Canada’s largest aquatic research facility and advanced platforms accelerating discoveries in health and the physical sciences. Researchers contribute to and benefit from a growing network of centres, institutes, and hubs driving discovery and industry partnership in areas like battery innovation and clean technologies, carbon capture and storage, additive manufacturing, AI and semiconductors, vaccine and immunotherapy development, genomics, cancer treatment, and much more.